Contact Lenses: Safe Use of Hydrogen Peroxide Solution

Medical Device Quality Management System Regulation Risk Management

GCP & Pharmacovigilance Compliance Symposium | D2S06 – Panel Discussion

FDA Direct: Removing Black Box Warnings for HRT (Part 2/2)

Tobacco Products Scientific Advisory Committee Meeting, October 7, 2025

Medical Device Quality Management System Regulation Design and Development

Good Clinical Practice & Pharmacovigilance Compliance Symposium | D3S06 - (PV): Regulatory Updates

At-Home COVID-19 Test Resources

November 13, 2025: Pediatric Advisory Committee Meeting (PAC)

FDA Expert Panel on Testosterone Replacement Therapy for Men

Good Clinical Practice & Pharmacovigilance Compliance Symposium | D3S05 - (PV): Future of...

FDA Direct: Removing Black Box Warnings for HRT (Part 1/2)

Public Meeting: Reauthorization of the Biosimilar User Fee Act

Good Clinical Practice & Pharmacovigilance Compliance Symposium | D3S04 - (PV): International...

Conversations on Cancer – Perspectives on Cancer Care Decision-Making Among Older Adults

GCP & Pharmacovigilance Compliance Symposium | D3S03-1 - (BE): Clinical Study Conduct

Good Clinical Practice & Pharmacovigilance Compliance Symposium | D3S07 – Q&A Discussion Panel

FDA Direct: FDA Awards Six National Priority Vouchers

Good Clinical Practice & Pharmacovigilance Compliance Symposium | D3S03-2 – Q&A Discussion Panel

Initiating the Removal of the “Black Box Warning” on Hormone Replacement Therapy

Healthier Choices Made Easier: Proposed Front-of-Package Nutrition Info Box